The Emirates Corporation for Health Services revealed the success of the medical team at Al Qassimi Hospital for Women, Childbirth and Children in installing the latest insulin pump for a type 1 diabetic with the “MinimedTM 780G” system for the first time in the UAE, a pioneering achievement in the world of modern medical technologies and using algorithms to improve patients’ glucose levels. .
The pump acts as a substitute for the natural pancreas by creating a finer balance between the doses of insulin and glucose and helps prevent cases of hypoglycemia, which facilitates living with diabetes and improves the quality of life for patients.
This achievement comes within the framework of the Foundation’s efforts to develop its treatment services and enhance confidence in the quality and efficiency of health care in the UAE.
The MinimedTM 780G Self-Adjusting Basal Insulin Pump with Auto-Correct Dosing offers many advanced features and unique benefits as it operates on a closed-loop system by working the pump and sensor together to provide glucose control to automatically adjust the injected dose.
The system also provides safety from low blood sugar, especially during sleep, thus avoiding potential health consequences.
Since the first weeks of using the new pump, positive results have been shown, as the percentage of time in the normal range has improved from 62% with the previous pump system to 94% with the new pump system without any hypoglycemic episodes, thanks to artificial intelligence and algorithms that allow to pause the insulin pump and restart it automatically without patient intervention.
His Excellency Dr. Youssef Mohammed Al Serkal, Director General of the Emirates Foundation for Health Services, stressed the importance of this achievement for Al Qassimi Hospital for Women, Childbirth and Children in supporting diabetes, providing comprehensive and innovative health and treatment services, enabling them to control the disease, coexist with it and reduce its complications to achieve the health and happiness of the patient and society, in addition to helping to improve Resources and raising quality for both health care providers and patients, and providing the latest global treatment systems.
He pointed to the efforts made to attract the latest treatment solutions for patients, provide a medical technical environment and a strong infrastructure for health services, within the framework of the Corporation’s strategy to provide integrated, sustainable, effective, innovative and high-quality health services that keep pace with the UAE vision and international standards and to enhance the country’s leadership and its constant endeavor to provide the latest medical innovations to patients.
Dr. Al Serkal pointed out the Foundation’s keenness to expand the network of global partnerships, continuous development of specialized cadres, providing appropriate training opportunities, and enabling them to use the latest medical solutions that improve the lives of diabetic patients to become more able to coexist with their disease in an optimal manner, through the development of practices to reach the highest levels of quality and safety. , in line with the directions and plans of the institution to establish a system of sustainable health services.
For her part, Dr. Safia Al Khaja, Director of Al Qassimi Hospital for Women, Maternity and Children, praised the continuous support provided by the Emirates Health Services Corporation in terms of providing the hospital with the latest medical equipment and technologies and enhancing the capabilities and skills of the medical staff with training and qualification to raise the efficiency of health services and achieve innovation in qualitative medical operations, pointing to the importance of the hospital’s achievement. In installing the latest insulin pump for a patient for the first time in the UAE, which contributes to achieving leadership in supporting diabetes and improving their quality of life in accordance with international best practices.
In turn, Dr. Elham Al Amiri, Consultant Pediatric Endocrinology and Diabetes at Al Qassimi Hospital for Women and Children, Vice President of the Diabetes Friends Society, explained that the MinimedTM 780G system is considered the closest to the natural pancreas and is the latest innovative way to continuously and orderly pump insulin throughout the day, which ensures stability in the blood sugar level. It gives the patient the opportunity to practice his normal life and coexist with the disease more flexibly and easily, and to get rid of the pain of repeated needles.
She noted that the system contains an innovative protection method that uses artificial intelligence to reduce the risk of both hypoglycemia and acute highs, and thus prevent diabetes complications. She stressed the need for patients to adhere to the doctor’s instructions and treatment protocol, as patients need close follow-up and a great deal of time and expertise to be devoted by a specialized diabetes team.